Refining the Understanding of Autoimmune Liver Disease Mortality

IF 6 2区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Liver International Pub Date : 2025-02-20 DOI:10.1111/liv.70044

Lingyun Zhu, Xingshi Hua, Libin Zhan

引用次数: 0

Abstract

The comprehensive population-based cohort study of autoimmune liver disease (AILD) mortality by Lasyte et al. provides valuable epidemiological insights. Several methodological perspectives merit consideration, including public database limitations, temporal mortality trends and the role of chronic kidney disease as an unmeasured covariate in mortality risk assessment. These methodological elements further enhance the interpretation of this robust AILD mortality analysis.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Liver International 医学-胃肠肝病学

CiteScore

13.90

自引率

4.50%

发文量

348

审稿时长

2 months

期刊介绍： Liver International promotes all aspects of the science of hepatology from basic research to applied clinical studies. Providing an international forum for the publication of high-quality original research in hepatology, it is an essential resource for everyone working on normal and abnormal structure and function in the liver and its constituent cells, including clinicians and basic scientists involved in the multi-disciplinary field of hepatology. The journal welcomes articles from all fields of hepatology, which may be published as original articles, brief definitive reports, reviews, mini-reviews, images in hepatology and letters to the Editor.